Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lab21 secures GBP2.2 million in equity financing
According to the company, the new funds will be used to progress its acquisition plan and to establish its US operations in South Carolina to expand its presence
According to the company, the new funds will be used to progress its acquisition plan and to establish its US operations in South Carolina to expand its presence
The Menaflex was determined to be substantially equivalent through the premarket notification process and is indicated for use in surgical procedures for the reinforcement and repair of soft
Under the terms of the agreement, Sangamo is expected to provide a worldwide, fully paid, perpetual, royalty free, non-exclusive, license for the use of certain ZFP Nuclease (ZFN) reagents for
ATL-962, which was discovered and created by Alizyme, is expected to be an agent to treat obesity and related diabetes or dyslipidemia through its mechanism of action which
According to the company, Tongbianling capsule is a generic traditional Chinese medicine and highly effective in treating one-time abdominal distention constipation, bedridden constipation and elderly chronic constipation. Tongbianling
In Northwest Biotherapeutics’s (NWBT) trial, the two patients who have received treatment attained eight months and six months without progression, respectively. Each of these NWBT patients had metastases
TPI 1100 is a inhaled inhibitor against phosphodiesterases (PDEs), PDE 4 and PDE 7. PDEs are a group of enzymes that are validated targets for chronic obstructive pulmonary
AstraZeneca is evaluating the contents of the complete response letter (CRL) and the proposed labeling revisions. AstraZeneca will continue discussions with the FDA and will provide a response
The drug candidate is currently in a Phase I/II clinical trial for the treatment of recurrent malignant melanoma. The company had previously received orphan designation for 131I-TM601 in
The relationship between the Hubbard and Harrington health systems has the potential to collaborate in ventures designed in the best interest of their patients, said Harrington Hospital. Chris